Cargando…
CEA-delta could be a biomarker of tumor phenotype, clinical stage, and chemotherapeutic response in rectal cancer with OCT4-positive cancer stem cells
BACKGROUND: There is very limited evidence on biomarkers for evaluating the clinical behavior and therapeutic response in rectal cancer (RC) with positive expression of cancer stem cells (CSCs). METHODS: An exploratory prospective study was conducted, which included fresh samples of tumor tissue fro...
Autores principales: | Lozada-Martinez, Ivan David, Bolaño-Romero, Maria Paz, Lambis-Anaya, Lina, Liscano, Yamil, Suarez-Causado, Amileth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514348/ https://www.ncbi.nlm.nih.gov/pubmed/37746252 http://dx.doi.org/10.3389/fonc.2023.1258863 |
Ejemplares similares
-
High OCT4 Expression Might Be Associated with an Aggressive Phenotype in Rectal Cancer
por: Lambis-Anaya, Lina, et al.
Publicado: (2023) -
Surgical outcomes and factors associated with postoperative complications of colorectal cancer in a Colombian Caribbean population: Results from a regional referral hospital
por: Dagobeth, Edgar Ernesto Vergara, et al.
Publicado: (2022) -
Multiple myeloma presenting as CEA-producing rectal cancer
por: Talamo, Giampaolo, et al.
Publicado: (2010) -
Prognostic Value of Postoperative CEA Clearance in Rectal Cancer Patients with High Preoperative CEA Levels
por: Kim, Jeong Yeon, et al.
Publicado: (2009) -
Elevated CEA is associated with worse survival in recurrent rectal cancer
por: Cho, Won Kyung, et al.
Publicado: (2017)